Anti-Cancer Agents and Biological Therapy
Clinical Practice Guidelines
Latest ESMO videos
E-Learning
ESMO E-Learning: Treatment of Locally Advanced NSCLC with Chemo-radiotherapy
ESMO E-Learning: PARP Inhibitors: Past, Present and Future
ESMO E-Learning: Cardiotoxicity in Oncology Practice
ESMO V-Learning: BRCA Across Tumour Types
ESMO E-Learning: Testicular Cancer: Treatment Strategies and Fertility Preservation
Meeting resources
Participants clinical case discussion: Metastatic clear cell renal cancer: a patient case of exceptional response and uncommon toxicity
Presenter: I. Zerdes, SE
Session: SESSION 6 - Focus on toxicity and duration of therapy
Resources:
Slides
Participants clinical case discussion: Severe combined cardiac and neuromuscular toxicity from 1st line immune-based combination in mRCC: a case report
Presenter: M. Rosellini, IT
Session: SESSION 6 - Focus on toxicity and duration of therapy
Resources:
Slides
Participants clinical case discussion: Multidisciplinary management of overlapping hepatotoxicity in a patient with mccRCC during first-line immuno-based treatment
Presenter: E. Tassinari, IT
Session: SESSION 6 - Focus on toxicity and duration of therapy
Resources:
Slides
FGR inhibitor and ADC toxicity management
Presenter: M. van der Heijden, NL
Session: SESSION 1 - Bladder Cancer – Part I
Resources:
Slides
ADCs in Thoracic Oncology: Current Standards and Lessons Learned
Presenter: Egbert Smit
Session: ADCs: The new promising therapy?
Resources:
Slides
Webcast